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Abstract: Generalised reviews of RNA interference (RNAi) in invertebrates, and for use in 
aquaculture, have taken for granted that RNAi pathways operate in molluscs, but inspection 
of such reviews show little specific evidence of such activity in molluscs. This review was 
to understand what specific research had been conducted on RNAi in molluscs, particularly 
with regard to aquaculture. There were questions of whether RNAi in molluscs functions 
similarly to the paradigm established for most eukaryotes or, alternatively, was it more 
similar to the ecdozoa and how RNAi may relate to disease control in aquaculture? RNAi in 
molluscs appears to have been only investigated in about 14 species, mostly as a gene 
silencing phenomenon. We can infer that microRNAs including let-7 are functional in 
molluscs. The genes/proteins involved in the actual RNAi pathways have only been 
rudimentarily investigated, so how homologous the genes and proteins are to other metazoa 
is unknown. Furthermore, how many different genes for each activity in the RNAi pathway 
are also unknown? The cephalopods have been greatly overlooked with only a single RNAi 
gene-silencing study found. The long dsRNA-linked interferon pathways seem to be present 
in molluscs, unlike some other invertebrates and could be used to reduce disease states in 
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aquaculture. In particular, interferon regulatory factor genes have been found in molluscs of 
aquacultural importance such as Crassostrea, Mytilus, Pinctada and Haliotis. Two possible 
aquaculture scenarios are discussed, zoonotic norovirus and ostreid herpesvirus 1 to illustrate 
the possibilities. The entire field of RNAi in molluscs looks ripe for scientific exploitation 
and practical application. 
Keywords: RNA interference; mollusc; interferon; aquaculture; norovirus; ostreid 
herpesvirus 1 
 
1. Introduction 
RNA interference (RNAi) has proved to be a very powerful tool in biomedicine for the investigation 
of gene function by gene silencing and for the control of virus by lowering mortality in various animals. 
Despite many papers and review articles [1] describing the pathway in invertebrates [2] and  
aquaculture [3,4], when the articles are examined in detail, the invertebrates examined include  
insects [5], crustaceans [4] and nematodes [6]. Conspicuous by their absence from such reviews are the 
Lophotrochozoa, which includes the molluscs and the annelids. RNAi appears not to have been widely 
used in molluscs despite their importance as seafood, in aquaculture, as plant pests and as intermediate 
hosts of important animal parasites. This review was to delimit exactly what information was available 
on RNAi in molluscs and where RNAi might be applied in novel situations like aquaculture. 
The RNAi pathway was first discovered in plants as a gene silencing phenomena. It was later revealed 
in nematodes where the term RNA interference was coined [7]. It can be described simply as a series of 
proteins which cleave dsRNA in a sequence-specific manner and have the effect of down regulating or 
silencing genes. Interestingly, there appears to be a non-sequence specific component triggered by long 
dsRNA that confers a protective effect against pathogens. This component probably works through the 
genes homologous to the interferon pathway in vertebrates but all components may not be functional in 
all invertebrates (see later). 
The most recent common ancestor of eukaryotes possessed an early RNAi system. It is clear that 
molluscs have a functioning, efficient RNAi pathway because the RNAi pathway has been used by a 
number of researchers to investigate gene function by down regulation of the genes of interest. Such 
studies have included cephalopods [8], bivalves [9–11], and both terrestrial [12,13] and marine 
gastropods [14]. Whilst the genes of the RNAi pathway in molluscs are likely to be homologous to other 
eukaryote pathways, differences do exist between and within phyla. At least two species of Leishmania [15], 
Trypansoma cruzi [16] and many fungi [17] lack the RNAi pathway completely or most components of 
it. In addition, the ecdozoa appear to lack the interferon system that is linked into and triggered by 
dsRNA (see below). Some otherwise widespread microRNAs are missing from ctenophores, cnidarians, 
porifera, unicellular organisms and plants [18]. A few of the apparent differences may be due to using 
different names in different phyla for the same functional protein. This is due to the three main groups 
of scientists working on different animal models (mammals, rodents and humans; Caenorhabditis 
elegans, and Drosophila) with each group developing their own nomenclature for functionally 
homologous genes. 
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There has been no attempt to actually catalogue what components of the RNAi pathway have been 
discovered in molluscs and which components are yet to be investigated. This review identifies what 
homologous components have been identified in molluscs, where the major gaps in knowledge are and 
whether there enough data to understand if there are differences in the major phylogenetic lines of 
molluscs. Within the existing knowledge of RNAi in molluscs, is it possible to use this information for 
practical outcomes, particularly in bivalve or abalone aquaculture. 
2. Interfering RNAs 
2.1. MicroRNA Interference; In the Beginning? 
MicroRNAs are approximately 22 nucleotides (nt) in length with 2 nt overhangs on the 3′ ends [19]. 
They are non-protein coding RNAs that are encoded in the genome of most eukaryotes. They regulate 
almost all gene expression and have been especially linked to the development of animals. They are 
often linked to gene repression or down regulation but can enhance expression of genes by repressing 
repressors. One of the interesting characteristics of microRNA is that they can be slightly mismatched 
in complementarities to the sequence they are binding to and repression will occur. This allows 
microRNAs the ability to imperfectly target many genes for regulation at the same time. This is contrary 
to short interfering RNAs which tend to be exact compliments of their target sequence.  
Five microRNA constructed as stem-loop sequences (miR-1a-1, -34a, -133a, -125b, -29b and -2a) 
conserved across invertebrate species were shown to be up-regulated in the foot of frozen intertidal 
gastropod, Littorina littorea and three (miR-1a-1, -34a, -29b) in the hepatopancreas [20]. Dicer was also 
up-regulated. This discovery of these microRNAs that are conserved and widespread across 
invertebrates including coelenterates, sponges, polychaetes, nematodes and urichordates allows us to 
infer they would be present in all molluscs and likely to be operational. In other animals, these miRNAs 
function as follows: miR-1 regulates heat shock protein 60 which affects the myocardium [21]; miR-34 
inhibits SIRT1 which affects the cell cycle and apoptosis [22]; miR-133 negative regulates many signals 
including K+ channels [21]; miR-125 down regulates p53 tumour suppressor gene [23]; miR-29 targets 
many cancer associated genes [24]; miR-2 affects both neural development and apoptotic genes [25]. 
Primary RNAs that are going to be processed into mature miRNAs undergo a series of modifications 
after transcription to arrive at the functional state. Initially, the primary microRNA is transcribed, 
captured by a dsRNA-binding protein called Pasha (or DGCR8 in humans) (Figure 1). This complexes 
with Drosha, a RNase III which trims it to about 65–70 nt of mainly complementary nucleotides. Then 
the trimmed microRNA form a secondary stem-loop (hairpin) shape [19]. These stem-loop precursor 
microRNAs are exported out of the nucleus by the classic Ran-GTP dependent karyopherin, Exportin 5 
which in many animals [26] has been characterised as critical [27]. 
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Figure 1. The components of the RNA interference pathway likely to be present in molluscs. 
The microRNA pathway encoded in the mollusc genome links via Dicer into the P-bodies 
for processing into effective RNAi. Cytoplasmic dsRNA passes from endosomes via Dicer 
to P-bodies stimulating the signaling α, β-interferon trans-activating γ-interferon in other cells.  
Once the hairpin has exited the nucleus, it is bound by Dicer 1 ribonuclease having a dsRNA-binding 
site which cuts off the loop and shortens the stem to 21–25 nt with a 2 nt overhang at the 3′ end of both 
strands. Now the RNA-induced silencing complex (RISC) or P-body forms. RISC consists of a  
HIV-Transactivating response RNA-Binding Protein (TRBP) (also called loquacious in insects) to 
capture the RNA; an endoRNase H, Argonaute 1 with a PIWI cleavage domain; and Dicer 1 containing 
the template RNA. One strand of the dsRNA is degraded leaving a single stranded, mature microRNA. 
In most animals, the complimentary template mRNA binds to the RISC containing the short imperfect  
21–25 nt RNA which stays bound and is called the guide strand. Argonaute 1 does not cleave the mRNA 
unless it is a perfect or near perfect match. Perhaps this silencing mechanism is due to the 3′ microRNA 
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interfering with the mRNA polyA tail repressing translation of the gene’s mRNA [28]. However, 
interference at both the mRNA 5′ cap (m7Gppp) and the 3′ ends is necessary for maximum repression [28]. 
In molluscs, of all the key enzymes in the RNAi system, only Dicer has been found by immunoreactivity 
with a rabbit anti-Dicer in the intertidal snail Littorina littorea [20]. However, a search of NCBI 
GenBank shows unpublished Dicer homologous sequences (P < 10−5) and sequences for other key 
enzymes in the RNAi system in other molluscs (Table 1). 
Table 1. The species of each major molluscan group that has gene sequences involved in the 
RNA interference pathway available on NCBI GenBank. 
Enzyme in RNAi Pathway Number in Bivalves Number in Gastropods Number in Cephalopods
Argonaute 2 with  
PIWI domain 
 Biomphalaria glabrata  
Dicer Argopecten purpuratus Littorina littorea  
Drosha    
HIV-TRBP = loquacious    
Interferon Regulatory Factor 
Crassostrea gigas 
Hyriopsis cumingii 
Ostrea edulis 
Pinctada fucata 
Haliotis discus 
 
 
Pasha = DGCR8-like  Littorina littorea  
Toll-like Receptor 3 
Chlamys farreri 
Crassostrea gigas 
Mytilus galloprovincialis
Biomphalaria glabrata  
Within the stem of one microRNA, a 21 nt sequence complimentary to 3′ untranslated region called 
let-7 (UGAUAUGUUGGAUGAUGGAGU) is highly conserved across most eukaryotes including 
molluscs but excluding ctenophores, cnidarians, porifera, unicellular organisms and plants [18]. let-7 
microRNA appears to function as the repressor of a repressor allowing the mRNA of a gene to be 
expressed. In the nudibranch, Phestilla sibogae and the polychaete, Hydroides elegans expression was 
prominent in adults but not larvae. Interestingly, a bioinformatical search in molluscs by the authors for 
complementary DNA transcripts of the let-7 sequence revealed bipartite signals suggesting functionality 
at 10–11 nt length or splicing to produce the full 21 nt signal. 
2.2. Short Interfering RNA (siRNA) 
siRNA uses the same RISC/P-body components but differs from the microRNA in a number of ways. 
siRNA is always cytoplasmic being induced by internalisation of dsRNA most often through the plasma 
membrane associated with SID-1 (systemic RNAi defective) conducting channels [29]. siRNA induction 
is via long dsRNA that are bound by R2D2 in Drosophila, homologous to RDE-4 in C. elegans and 
other nematodes which have two, in tandem, RNA-binding domains and stimulate the production of 
Dicer or at least stabilise it [30]. Many investigations with siRNA deliver the complementary 21–25 nt 
template directly bypassing R2D2/RDE-4 proteins. To function, the complementary template in 
Argonaute 2 should be exact, rarely one or extremely rarely, two base pairs different. The mRNA of the 
gene is always cleaved at one specific site, opposite and after 10 nt from the 5′ end of the guide strand [31]. 
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Long dsRNA have been preferred in intervention studies over siRNA as they are believed to work 
better. This is perceived to be due to the ability of multiple siRNA being able to be generated by Dicer 
from the long dsRNA template rather than relying on just one short match. Also, long dsRNAs have 
been able to generate non-sequence specific protection either by enhanced Dicer induction [30] or 
stimulation of γ-interferon (see below). One of the questions needed to be answered is: at what length 
does a siRNA become a long dsRNA (see below) in terms of activity? The answer might be; there is no 
difference (see 30). Furthermore, [32,33] showed that siRNA of 21 nt was also able to generate  
non-sequence specific protection possibly by enhanced expression of Dicer which is functioning as a 
non-sequence specific ribonuclease. 
2.3. Long dsRNA Linked to Interferon? 
Long dsRNA are processed the same way as described above for siRNA. However, if the process of 
internalisation involves the formation of endosomes, the dsRNA is likely to trigger the Toll-like receptor 
3 (TLR3). In the Zhikong scallop (Chlamys farreri), five functional genes of the Toll-like pathway have 
been found by amino acid homology and tested by ELISA and RNAi [11]. In humans, TLR3 will trigger 
a non-sequence dependent antiviral response through the interferon pathway, particularly γ-interferon. 
TLR3 is unique amongst TLRs in that it does not function through MyD88 (myeloid differentiation 
primary response gene 88). Instead, homodimers of interferon regulatory factor (IRF) 3 and IRF 7 
promote transcription of the α/β-interferons which signal other cells in a trans-cell manner to produce 
the glycoprotein, γ-interferon. Interferons are non-specific inhibitors of mRNA transcription that 
generally slow down rapid replicators like viruses and tumour cells and turn on many other genes of the 
innate pathways of immunity to eliminate pathogens. Interferons are also suspected to coat receptors 
blocking the uptake of viruses [34]. 
In invertebrates, the functional presence of this interferon pathway is clouded. Using bioinformatical 
searches for the conserved N-terminal DNA binding domain of IRF and the C-terminal IRF association 
domain 1 or 2 (IAD1, IAD2), [35] did not detect IRF genes in nematodes or arthropods but they did in 
molluscs with 2–7 different genes in 4 functional clusters. Those molluscs deemed positive for IRF genes 
included the marine gastropods, Aplysia california, Lottia gigantea and the bivalves Crassostrea gigas, 
Mytilus edulis and Mytilus californicus. Furthermore, [36] have characterised a homologous IRF 2 
(within the IRF 1 family) from the pearl oyster Pinctada fucata. Indeed, [37] cloned a myxovirus 
resistance (Mx) gene from the disk abalone (Haliotis discus), one of the most studied interferon type 1 
(α/β)-inducing proteins known. They showed that it was functional when stimulated with the artificial 
viral nucleic acid analogue, poly-inosinic:cytidylic acid (poly I:C). Similarly, [38] showed poly-I:C 
induced an immune response against ostreid herpesvirus 1(OsHV-1) which included up regulation of 
toll-like receptors, MyD88, interferon regulatory factor and protein kinase R which are indicators of a 
type-1 interferon response. 
Furthermore, also in disc abalone, [39] demonstrated the presence of another interferon-induced gene; 
Gamma-interferon Inducible Lysosomal Thiol reductase (GILT) which reduces the disulphide bonds 
associated with the major histocompatibility complex class II restricted antigens. In addition, in the 
Japanese pearl oyster (Pinctada fucata), [34] used a recombinant feline ω-interferon to block akoya 
virus. In the best treatment, only 18% of oysters died from the virus whilst 100% of untreated oysters 
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died. Survivors showed less muscle damage and extensive repair of muscle tissues that had been 
damaged. However when delivered at the same dose, α-interferon which is a signaling interferon rather 
than an effector molecule, had no effect on oyster mortalities due to the akoya virus.  
In summary, genes for the interferon pathway and interferon-induced genes exist and are functional 
in a range of molluscs; molluscs tolerate injection of therapeutic doses of ω-interferon and these doses 
prevent virus-induced mortality as does the artificial virus analogue poly I:C. Despite the paucity of 
direct evidence in the primary literature on molluscs of an interferon-based pathway induced via dsRNA 
and TLR 3, there is accumulated evidence that this pathway is functioning in molluscs.  
3. Possible Practical Uses of RNAi by Mollusc-Based Industries 
Whilst there is a plethora of potential applications for RNAi, this review will focus on two diseases 
related to the aquaculture of bivalves, one of major zoonotic potential, Norovirus and one of major 
epizootic potential, ostreid herpesvirus 1 (OsHV-1). 
3.1. Norovirus 
Noroviruses are responsible for almost half the food borne illnesses and more than 90% of the  
non-bacterial food borne outbreaks in the USA [40]. Noroviruses are members of family Caliciviridae 
and as such consist of non-enveloped viruses containing positive sense ssRNA. They are cosmopolitan 
in distribution and responsible for winter gastroenteritis epidemics worldwide. There are two main 
genotypes in humans, GI and GII. Noroviruses bind to carbohydrate moieties particularly the fucose 
residue in the gut and on red blood cells that are similar to the Lewis, H and human histo-blood group 
antigens (HBGA). In humans, HBGA leads to a differential susceptibility to GI norovirus. HBGA-A is 
the most susceptible and HBGA-B is the least [41]. However, one of the latest recognised norovirus 
genotypes, GII.4 discovered in Sydney, Australia was not influenced by human histo-blood group 
antigens as it binds to a sialic acid ligand found widespread in most tissues [42]. 
It would be easy to deliver RNAi against norovirus to oysters in an experimental situation that could 
be applied at the depuration stage. For instance, a plasmid can be designed to produce mRNA 
complementary to the capsid gene or the viral encoded C3 protease. This would bind to the mRNA 
producing a dsRNA molecule that Dicer would target for destruction. As these two genes are viral 
encoded genes, it would be highly unlikely to have any off-target effects. This approach has already 
worked in insects against a penaeid virus [43] and in penaeids [33]. Oral delivery could be by live, 
probiotic bacteria [43], perhaps by killed bacteria or chitosan nanoparticles [44] which have been shown 
to be effective in other invertebrates. A protocol delivering dsRNA via the diet [33] would be even better 
as these dsRNAs decay to become inactive within about four weeks [44].  
For RNAi intervention to decrease the titre of the norovirus in oysters, there has to be a phase of 
naked RNA in the cytoplasm of the cells of the oyster. Unfortunately, this information is lacking in 
oysters but the implication from the literature is that oysters are only an accumulative host of the virus [45]. 
An elegant study including quantitative PCR for norovirus in Crassostrea virginica and Crassostrea 
ariakensis was undertaken by [46] but unfortunately they did not report the viral titres. Instead they used 
a logistic regression model which produces odds ratios. Their endpoint day was day 29 for C. ariakensis 
but as the experiment only ran for that period, it is impossible to know if that was the day of extinction 
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for the viral titre. However, in C. virginica the endpoint day was 22–25, dependent on temperature, 
which shows slow viral clearing but not the lack of viral replication.  
If indeed oysters are only an accumulative host and not a replicative host as the literature suggests, 
there is another RNAi approach that could be attempted. For accumulation of norovirus, a 
fucosesyltransferase gene (fstf gene) like the human FUT2 must be operational to produce terminal 
fucose residues to efficiently bind the norovirus. Interestingly, about 20% of humans are considered 
“non-secretors” if this gene is mutated. Non-secretors are almost totally resistant to norovirus [41] except 
for GII.4. There is no known detrimental health changes in humans for mutation of this gene as other 
genes like FUT1 maybe be able to compensate [47]. This gives a level of safety to consumers of oysters 
RNAi-treated to knockdown FUT2. Furthermore, there is only a 2% homology between bivalve and 
human FUT2, so it should be very easy to design a RNAi against molluscan FUT2 that does not function 
in humans. Therefore a RNAi targeting FUT2, which has already been proven to down regulate FUT2 
in cell cultures [47], could be delivered as outlined above to depurating oysters. A bioinformatical search 
by the authors has identified a fucose-binding lectin gene in molluscs including oysters suggesting the 
pathway is present. It may enhance depuration if the fstf gene needs to be active in the oyster for 
norovirus retention. This could be tested experimentally and maybe a therapy for speeding up depuration 
or perhaps a mutated FUT2 could be a gene marker for resistance to norovirus in selective breeding of 
oysters in hatcheries. 
3.2. Ostreid Herpesvirus 1 (OsHV-1) 
Ostreid herpesvirus 1 (OsHV-1) is a worldwide virus which causes epizootic mortalities up to 100% 
associated with rising water temperatures [48]. OSHV-1 infects many species of bivalves including the 
widely dispersed and cultivated Crassostrea gigas. It has commonly caused summer mortality and it has 
become more worrisome with the rising temperatures associated with global warming. Spat (newly 
settled bivalves) and juveniles are particularly vulnerable with mortalities [49] within 7–10 days but 
infection is seen as early as 3–4 days [48]. Herpesviruses have been known in oysters since the 1960’s 
but only really have become a problem since the advent of oyster hatcheries where many of the progeny 
can be infected, thus producing a noticeable epizootic. Survivors of epizootics are believed to be carriers 
with high qPCR titres being significantly associated with mortalities whilst low titres are not [50]. 
Recently in 2005, a new virulent biotype, µvar OsHV-1 arose and has spread worldwide to become a 
major problem since 2008 [51]. 
RNAi could be a solution to OSHV-1 which is highly probable to be effective over time. Viral titres 
in invertebrates as measured by qPCR are likely to drop by 90% when appropriate RNAi is applied [4]. 
The capsid gene of OsHV-1 is a likely target for intervention. The question becomes one of delivery. As 
the spat are infected so early in life, the spawning adults have to be targeted for RNAi. Incorporation of 
a plasmid with complimentary DNA to the target gene into the oyster in a probiotic bacterium would be 
easy, but this must be done in a hatchery. As it may be possible to produce 100% sterile triploid oysters [52] 
although recent studies suggest that limited reversion to normal chromosome counts is possible [53], 
triploidy could be coupled with the introduction of the bacterium so there would be a reduced chance of 
spread of the plasmid to wild oysters via gametes. Since OsHV-1 is a problem exacerbated by hatcheries, 
then where hatcheries are being used, they can become part of the solution. Possibly dramatically 
J. Mar. Sci. Eng. 2015, 3 95 
 
 
reducing one of the sources of environmental contamination will allow wild oysters time to become 
more resistant as resistance to OsHV-1 has been shown to be genetically highly variable [50] and 
therefore likely to be highly heritable. 
4. Conclusions 
Relative to other animal groups, the studies of the RNA interference pathways in molluscs have been 
comparatively sparse and all the information known is probably based on a mosaic of about fourteen 
species. However, there appears to be a constant theme of homologous proteins and functioning 
similarities in the pathways rather than differences. The area needing most attention is the cephalopods 
for which there is a dearth of knowledge and may be the most likely place to find novel components. 
There is no data on how many slightly different enzymes in the RNAi pathway there might be in each 
mollusc. For instance, Penaeus vannamei has two different Argonautes with slightly different 
capabilities [54] and up to four different Dicers have been found in plants [55]. Nevertheless, it seems 
reasonable to predict that of all the invertebrate groups so far studied, molluscs look likely to follow the 
paradigms for RNAi set by other studies in more recently evolved eukaryotes. This would suggest that 
RNAi is likely to be a major new tool for intervention against diseases in molluscs, particularly via 
hatcheries for aquaculture. 
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